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Strengths and limitations of the study
 ► The simulation modelling study included a compre-
hensive collection of patient level data from both the 
prehospital and intrahospital acute stroke pathway.
 ► A simulation- based approach, as presented in this 
paper, can be instrumental in facilitating a broad 
overview of the set- up and performance of stroke 
pathways.
 ► Effects of capacity constraints on patients’ waiting 
for care services are not explicitly modelled given 
their high priorities, allowing them to queue jump.
 ► Costs items associated with the proposed interven-
tions could not be collected and controlled for.
 ► Estimations of time intervals used for model building 
might have changed over time.
AbStrACt
Objectives To assess potential increases in intravenous 
thrombolysis (IVT) rates given particular interventions in 
the stroke care pathway.
Design Simulation modelling was used to compare the 
performance of the current pathway, best practices based 
on literature review and an optimised model.
Setting Four hospitals located in the North of the 
Netherlands, as part of a centralised organisational model.
Participants Ischaemic stroke patients prospectively 
ascertained from February to August 2010.
Intervention The interventions investigated included 
efforts aimed at patient response and mode of referral, 
prehospital triage and intrahospital delays.
Primary and secondary outcome measures The 
primary outcome measure was thrombolysis utilisation. 
Secondary measures were onset- treatment time (OTT) 
and the proportion of patients with excellent functional 
outcome (modified Rankin scale (mRS) 0–1) at 90 days.
results Of 280 patients with ischaemic stroke, 125 
(44.6%) arrived at the hospital within 4.5 hours, and 
61 (21.8%) received IVT. The largest improvements in 
IVT treatment rates, OTT and the proportion of patients 
with mRS scores of 0–1 can be expected when patient 
response is limited to 15 min (IVT rate +5.8%; OTT −6 min; 
excellent mRS scores +0.2%), door- to- needle time to 
20 min (IVT rate +4.8%; OTT −28 min; excellent mRS 
scores+3.2%) and 911 calls are increased to 60% (IVT 
rate +2.9%; OTT −2 min; excellent mRS scores+0.2%). 
The combined implementation of all potential best 
practices could increase IVT rates by 19.7% and reduce 
OTT by 56 min.
Conclusions Improving IVT rates to well above 30% 
appears possible if all known best practices are 
implemented.
IntrODuCtIOn
Intravenous thrombolysis (IVT) is an effec-
tive therapy for acute ischaemic stroke up to 
4.5 hours after the onset of symptoms.1 2 This 
therapy is substantially underused, however, 
with 8%–10% of all stroke patients worldwide 
currently receiving IVT.3 4 In contrast, treat-
ment rates of up to 35% have been achieved 
in optimised settings.5 6 The organisation of 
stroke care is an important factor in realising 
timely hospital arrival and treatment.7 8 The 
centralisation of care at designated stroke 
centres has been demonstrated to increase 
the proportion of patients arriving at the 
hospital in time for acute treatment.9–11 
Given the substantial decrease in the benefit 
of treatment with increasing time delays, 
further efforts to expedite hospital arrival 
and subsequent treatment remain of crucial 
importance.12 13
Various studies have investigated factors 
associated with efficiency in each part of the 
acute stroke pathway. Although it has been 
generally established that delay on the part 
of patients and/or bystanders is a primary 
factor in delaying hospital arrival,14 interven-
tions aimed at improving optimal response 
by calling 911 immediately have exhibited 
varying success, and many lack sustained 
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Table 1 Descriptive statistics of activity durations and 
diagnostics
Number of patients 280
Age in years (SD) 70 (14)
Male (%) 156 (56)
Patient responsiveness
  Time from symptom onset to call for help, 
valid cases (%)
152 (54)
  Median, min (IQR) 41 (5–130)
  Mode of referral (%)
  General practitioner 129 (46)
  911 84 (30)
  Self- referral 60 (21)
  In- hospital patients 7 (3)
Pathway set- up
  Transported by EMS (%) 213 (76)
  Median response time, min (IQR) 9 (7–12)
  Median on scene time, min (IQR) 20 (15–25)
  Median transportation time, min (IQR) 17 (9–22)
  Median time from hospital arrival to 
neurological examination, min (range)
2 (0–15)
  
  Median time from hospital arrival to CT 
examination min (IQR)
12 (6–15)
  Median time from hospital arrival to 
laboratory examination, min (IQR)
32 (27–37)
  Median door to IVT time, min (IQR) 35 (25–45)
EMS, emergency medical services; IVT, intravenous thrombolysis.
implementation15 (as is the case in other domains of 
medicine as well).16 Ambulance transportation to hospi-
tals that offer acute treatment is associated with shorter 
onset- to- door times, reductions in intrahospital delays 
and increases in treatment rates.15 17 18 The provision of 
acute treatment by a mobile stroke unit (MSU) before 
hospital arrival has been identified as a promising method 
for reducing time to IVT.19Another widely studied topic 
concerns reducing the time between hospital arrival and 
treatment (door- to- needle (DTN) time), with reported 
DTN times as low as 20 min.20
The aforementioned studies have demonstrated clear 
benefits in terms of time saved. They nevertheless lack a 
broader overview of pathway set- up and its performance. 
Instead of addressing the solution space as a whole, they 
target isolated elements of the stroke pathway. The lack 
of a broader overview is due in part to the predominant 
use of randomised controlled trials (RCT) as the main 
research vehicle. Given the effort involved in their set- 
up, RCT studies focus predominantly on separate and 
singular elements of pathway performance. They may 
therefore be less suitable for investigating complex care 
systems (eg, acute stroke treatment). In particular, timely 
hospital arrival and the treatment of acute stroke patients 
relies on a series of intertwined activities concerning 
patient diagnostics and transportation.
One potential alternative methodology is simulation 
modelling. Proceeding from a detailed description of both 
prehospital and intrahospital time delays and diagnostics, 
an accurate representation of pathway performance can 
be developed in silico, including the validation of IVT 
rates, time to treatment, patient outcomes (as measured 
by the modified Rankin Scale (mRS)) and other clinically 
relevant outcome measures.21 22 This approach would 
allow the examination of all time delays and diagnostic 
steps, thereby providing clinicians and policymakers 
with an accurate overview of obstacles currently existing 
within care pathways. In addition, scenarios for hypothet-
ical approaches to improvement based on clinical guide-
lines, literature observations and/or expert opinion can 
be modelled and studied for their cumulative effects on 
relevant clinical outcome measures.23 24
The aims of this simulation- modelling study were (1) 
to estimate the cumulative potential for improving IVT 
utilisation by implementing best practices on the organ-
isation of the stroke pathway and, subsequently, (2) to 
explore areas in which further improvement is needed in 
order to achieve a fully optimised setting, in addition to 
identifying obstacles to such optimisation.
MethODS
This article is based on a 6- month, prospective, multi- 
centre study performed in a centralised organisational 
stroke- care setting in the north of the Netherlands 
from February through July 2010.9 Patient- level data 
were collected on time delays and diagnostics, thereby 
providing detailed insight into patient flow and potential 
obstacles in both the prehospital and intrahospital path-
ways (table 1). A schematic overview of patient flow and 
the steps included in the analyses is presented in figure 1.
Setting and participants
The centralised organisational setting consisted of four 
hospitals in the northern region of the Netherlands, with 
IVT being administered only in the University Medical 
Center Groningen (UMCG). Together with the other 
three community hospitals, general practitioner (GP) 
offices and emergency medical services (EMS), arrange-
ments were made to transport presumed stroke victims 
immediately to the UMCG, thus bypassing community 
hospitals that might have been located closer to the 
patient’s location. The international protocol for IVT 
(adjusted European Cooperative Acute Stroke Study 
(ECASS) III25 and the regional protocol for prehospital 
management were followed. The region addressed in 
this study comprises approximately 580 000 inhabitants, 
with a population density of 250 inhabitants/km2. The 
study population consisted of ischaemic stroke patients 
admitted to all four hospitals between February and 
August 2010. Case ascertainment was confirmed by the 
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Figure 1 Acute stroke pathway: description of activities. EMS, emergency medical services; GP, general practitioner; N, no; 
tPA, tissue plasminogen activator; Y, yes.
final hospital discharge diagnosis of ischaemic stroke, 
thereby excluding stroke mimics.
The data collected included information on time 
delays and diagnostics along the entire stroke chain. 
Stroke care pathways can be described in several distinct 
phases: hyperacute (emergency), acute and rehabili-
tation. Within this study we focused on the hyperacute 
phase, ranging from symptom onset until acute treatment 
with IVT. Time delays included the time from symptom 
onset to call for help, delay at first response (GP or EMS 
services), EMS transport times and intrahospital diagnos-
tics, which included time from hospital arrival to neuro-
logical examination, CT scan, laboratory testing and IVT.
Simulation model
The current study was performed using a previously vali-
dated simulation model.24 More detailed information 
on simulation modelling methodology, input param-
eters, model and model data used may be found in a 
online supplementary file. This model was populated 
with patient- level data from a previous observational 
study.9 The model was validated by comparing IVT treat-
ment percentages and onset- treatment time (OTT) to 
those reported in the observational study. The next step 
consisted of developing scenarios in which alternative 
pathway set- ups, associated time delays and diagnostics 
were imputed based on literature observations, clinical 
guidelines and expert opinion. Using the simulation 
model, hypothetical patients were passed through the 
system, estimating the impact of intervening at various 
points in the acute stroke pathway. Interventions were 
modelled by changing the underlying statistical distri-
butions to redistribute patients across time delays and 
diagnostics.26
Scenarios
We used simulation modelling to investigate the effects 
of changing pathway set- ups, based on three models: 
(1) a baseline model of acute stroke care; (2) a model 
reflecting best practices, based on a review of the current 
literature, clinical guidelines and expert opinion; and 
(3) an optimised model. Interventions were selected 
according to the obstacles identified in the current 
centralised organisational model. Obstacles within the 
study setting included delayed emergency response by 
patients following symptom onset, mode of referral (GP 
or 911), time spent on the scene by ambulance personnel 
and intrahospital delays. The simulation model was used 
to perform hypothetical interventions in the pathway to 
calculate clinically relevant outcomes.24 The outcomes 
were compared with the baseline performance of the 
current system to estimate the potential for improvement, 
to optimise system performance, and to identify obstacles 
that have yet to be overcome.
Baseline
The baseline model describes the performance of the 
centralised organisational model for acute stroke care, as 
described in the previous observational study.9 A descrip-
tion of time delays and diagnostics along each step of the 
pathway is provided in table 1.
Best practice
The scenarios and input parameters that were investi-
gated are described in table 2.
Patient responsiveness: We estimated the relative impact of 
reducing the time between stroke onset and call for help 
by patients, their families and/or bystanders by adjusting 
the distribution of their response times by a factor equal 
to the quotient of the respective median response times 
reported for best practices (15–30 min)27 28 and the base-
line scenario (41 min).
Mode of referral: We modelled a scenario in which 
patients, their families and/or bystanders predominantly 
(60%) chose 911 as the mode of entry.29 30
Time spent on the scene by ambulance personnel: In this 
scenario, we modelled the time spent on the scene by 
ambulance personnel following a 911 call by imposing an 
upper boundary on on- scene delay. Based on the guidelines 
of the American Stroke Association, the time spent on the 
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Table 2 Overview of scenarios and input parameters
Factor Baseline Scenarios Study Input parameters
Patient responsiveness
  1. Patient delay 41 min* A. Reduced to 30 min (best 
practice)
B. Reduced to 15 min (best 
practice)
C. Reduced to 0 min (optimised)
Salisbury et al27
Carroll et al28
Time from stroke onset 
to call for help
  2. Mode of referral 911 30% A. Transport by EMS increased to 
60% (best practice)
B. Transport by EMS increased to 
100% (optimised)
Barsan et al29, Chen et 
al30
Choice of route, choice 
of first responder
  3. Combined best 
practices patient
  responsiveness
  Combines scenarios 1B and 2A See factors 1 and 2
  4. Optimised patient 
responsiveness
  Combines scenarios 1C and 2B See factors 1 and 2
Pathway set- up     
  5. Response time first 
responders
  9 min* Response time first responders 
reduced to 0 min (optimised)
Delay first responder
  6. On scene time 
ambulance personnel
20 min* A. Reduced to 15 min (best 
practice)
B. Reduced to 10 min (best 
practice)
C. Reduced to 0 min (optimised)
Jauch et al37, Acker et 
al38,
Atkins et al36
EMS—time spent on 
scene
  7. Prehospital IVT by MSU
  transportation time
17 min* A. Transportation time reduced to 
0 min (best practice)
B. All ambulance delays reduced 
to 0 min (optimised)




  8. Door to IVT times 35 min* A. Reduced to 30 min (best 
practice)
B. Reduced to 25 min (best 
practice)
C. Reduced to 20 min (best 
practice)
D. Reduced to 0 min (optimised)
Zinkstok et al33, 
Meretoja et al34,
Meretoja et al20
Time to neurological 
consultation, time 
to neuroimaging 
examination, time to 
laboratory examination, 
decision making, IVT 
mixing
  9. Combined best 
practices pathway set- up
  Combines scenarios 6B, 7A and 
8C
See factors 6, 7 and 8
  10. Optimised pathway 
set- up
  Combines scenarios 5, 6C, 7B 
and 8D
See factors 5, 6, 7 and 
8
Patient responsiveness and pathway set- up




  Combines scenarios 3 and 9 See factors 3 and 9
  12. Optimised patient 
responsiveness and 
pathway set- up
  Combines scenarios 4 and 10 See factors 4 and 10
*Median.
EMS, emergency medical services; IVT, intravenous thrombolysis; MSU, mobile stroke unit.
scene should be no more than 15 min.31 We also modelled 
the implementation of a ‘scoop and run protocol’, which 
includes prompt transport (≤10 min) with initial manage-
ment efforts, while postponing elaborate triage.
Prehospital treatment by MSU: In this scenario, we modelled 
prehospital IVT provided by a MSU by adjusting only the 
transport time of the ambulance. Assuming that the MSU 
would be stationed at the hospital, we considered only 
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the transportation time from the hospital to the patient 
scene.
Intrahospital processes: Intrahospital delays comprise all 
activities performed between arrival at the hospital until the 
start of IVT (DTN time; see figure 1). Based on the guide-
lines of the American Stroke Association, DTN time should 
be no more than 60 min.32 Evidence from clinical practice 
suggests that DTN times within a range of 20–30 min are 
attainable.20 33 34
Combined best-practice scenarios
Three scenarios were performed in which best prac-
tices were combined for patient responsiveness and 
pathway set- up. Patient responsiveness was modelled by 
combining patient response with the mode of referral 
following stroke onset. Pathway set- up was modelled by 
combining prehospital and intrahospital best practices. A 
third scenario combines best practices for patient respon-
siveness and pathway set- up.
Optimised scenarios
Additional scenarios were defined to interpret findings 
on the effects of the implementation of best practices (or 
combinations thereof) by generating upper boundaries 
to pathway performance, thereby building on unrealisti-
cally optimistic assumptions. For the optimised scenarios, 
we extrapolated best practices by setting the parameter 
for associated time delays to 0 or by setting the diagnostic 
quality parameter to 100%.
Outcome measures
The primary outcome measure was the proportion of 
patients treated with IVT. Secondary outcome measures 
were the total process time (onset- to- treatment time), 
IVT within various time intervals (0–90, 91–180 and 
181–270 min), the proportion of patients with favourable 
outcomes at 90 days (mRS 0–1) and additional healthy 
life days (calculated using OTT estimates).12 35
Analysis
For each of the scenarios described above, we calculated 
new hypothetical IVT treatment rates and secondary 
outcome measures, based on the number of patients 
arriving in time for acute treatment at the hospital (ie, 
within 4 hours after symptom onset), the number treated 
with IVT and the time to treatment. χ2 tests were used to 
compare categorical variables.
ethics approval and patient consent
Informed consent was obtained from all subjects partic-
ipating in the prospective study9 and extended for the 
current simulation study.
Patient and public involvement
Patients and public were not involved in the design of this 
study. For this modelling study non- identifiable patient data 
was used. Study results will be disseminated through poster 
presentations and publication in peer- reviewed journals.
reSultS
This study reflects the experiences of 280 ischaemic stroke 
patients referred to the UMCG and three community 
hospitals, as part of a centralised organisational model. 
Baseline and demographic characteristics are described 
in table 1. In all, 125 (44.6%) patients arrived at the 
hospital within 4.5 hours, 61 (21.8%) received IVT, and 
the median OTT was 127 min. Of the patients receiving 
IVT, 17.0% were treated within 90 min of symptom onset. 
Patient delay, intrahospital delays and mode of referral 
(GP or 911) were identified as the greatest obstacles to 
receiving IVT (table 1).
Simulation experiments
The results of the simulation experiments are presented 
in table 3.
Patient responsiveness: If patients had contacted emer-
gency services sooner (ie, within 30 and 15 min), up to 
27.6% (CI 26.7% to 28.4%) of the total population would 
have been treated with IVT (table 3, Scenarios 1A and 
1B), and the OTT would have been reduced to 122 min 
(CI 121 to 124).27 28
Assuming a patient delay of 0 min (table 3, Scenario 
1C), 64.0% of the total population would have been 
treated with IVT, and the OTT would have been reduced 
to 92 min (CI 91 to 92).
Mode of referral: Assuming 60% of all patients contacting 
911 immediately following stroke onset (table 3, Scenario 
2A) increased the IVT rate to 24.6% (CI 23.8% to 25.5%) 
and reduced the OTT to 127 min (CI 125 to 128).29
If all patients (100%) had called 911 (table 3, Scenario 
2B), the IVT rates would have increased further to 28.4% 
(CI 27.5% to 29.3%), and the OTT would have been 
reduced to 124 min (CI 123 to 126).
Time spent on the scene by ambulance personnel: Shortening 
the time spent on the scene to 15 and 10 min (table 3, 
Scenarios 6A and 6B),36 increased the IVT treatment rate 
up to 23.3% (CI 22.4% to 24.1%) and reduced the OTT 
to 121 min (CI 120 to 123).37 38
Reducing time on the scene to 0 min resulted in a 
projected IVT rate of 24.7% (CI 23.8% to 25.5%) (table 3, 
Scenario 6C) and a decrease in the OTT to 114 min (CI 
112 to 116).
Prehospital treatment by MSU: In this set- up, 23.2% (CI 
22.4% to 24.0%) of patients would have been treated with 
IVT (table 3, Scenario 7A) and OTT would have been 
reduced to 121 min (CI 120 to 123).
The elimination of both the response time and trans-
portation time of the MSU (table 3, Scenario 7B) resulted 
in a projected 25.6% (CI 24.7% to 26.4%) of patients that 
could have received IVT and a reduction of the OTT to 
109 min (CI 107 to 110).
Intrahospital processes: If the DTN time had been short-
ened to a maximum of 30 and 20 min (table 3, Scenarios 
8A–C), up to 26.6% (CI 25.7% to 27.4%) of the total 
population would have been treated with IVT, and the 
OTT would have been reduced to 101 min (CI 99 to 103).
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If the DTN had been reduced to 0 min (table 3, 
Scenario 8D), 29.8% (CI 28.9% to 30.7%) of all patients 
would have been treated with IVT, and the OTT would 
have been reduced to 83 min (CI 81 to 85).
Combined best practice scenarios
Combining best practices for patient responsiveness and 
pathway set- up (table 3, scenario’s 3, 9, 11) resulted in up 
to 41.5% (CI 40.5% to 42.4%) of all patients being treated 
with IVT and reduced the OTT to 73 min (CI 72 to 74).
Optimised scenarios
Assuming optimised patient responsiveness (ie, all patients 
calling 911 immediately following stroke onset; table 3, 
Scenario 4) resulted in 64.3% of the total population (CI 
63.3% to 65.2%) being treated with IVT and reduced the 
OTT to 98 min (CI 97 to 98). The optimisation of pathway 
set- up (table 3, Scenario 10) resulted in 38.5% (CI 37.6% to 
39.5%) of all patients receiving IVT and reduced the OTT 
to 39 min (CI 37 to 40). The combination of all optimised 
scenarios (table 3, Scenario 12) resulted in a cumulative 
total of 97.7% (CI 97.4% to 98.0%) of all patients being 
treated with IVT and reduced the OTT to 0 min.
DISCuSSIOn
This study demonstrates that IVT treatment rates above 
30% would be possible if best practices were to be imple-
mented within our setting. We modelled several scenarios 
to generate insight into the potential for quality improve-
ments in our acute stroke chain of care. Although improve-
ments in patient responsiveness would yield the largest 
potential gains within our pathway, even modest changes 
in this regard are likely to be challenging and costly to 
achieve.16 In contrast, improvements in other areas (eg, 
intrahospital delays and time spent by ambulance personnel 
at the patient’s location) might be easier to achieve and 
would still lead to clinically relevant increases in IVT rates. 
As indicated in previous studies, even small reductions in 
time to treatment with IVT are associated with considerable 
increases in the length of healthy life, and they may require 
only relatively simple organisational changes involving 
minimal effort at little or no cost.12
The results of our study may be useful as a guide for 
prioritising interventions along the acute stroke pathway 
and for estimating their potential impact on the effec-
tiveness of the pathway. A simulation- based approach, 
as presented in this paper, can be instrumental in facili-
tating a broad overview of the set- up and performance of 
stroke pathways. This could provide clinicians and poli-
cymakers with speedy answers—at little effort or cost—
concerning how new or widely advocated practices could 
be used to improve their pathways, thus allowing them to 
direct investments to the interventions that matter most. 
It thus has the potential to replace RCT studies or serve 
as a precursor to a focussed RCT, which could be scoped 
as the net result of a simulation approach.
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In our study, we observed the greatest effects on 
IVT rates, time to treatment and patient outcomes 
after improving the responsiveness of patients and/or 
bystanders by reducing the time from symptom onset 
to the call for help, thereby expediting intrahospital 
care services and by increasing the number of 911 calls 
made by patients or bystanders. In contrast, a scenario in 
which prehospital transportation delays were reduced by 
the implementation of a MSU resulted in only moderate 
effects. Combining all of the best- practice scenarios 
resulted in a maximum of 41.5% of patients being 
treated with IVT. This is substantially higher than current 
benchmark figures on clinical practice, which suggest a 
maximum IVT rate of around 35%.6 39
Proceeding from a scenario in which best practices 
have been implemented, remaining challenges include 
realising further decreases in time delays in both the 
prehospital and intrahospital phases. The feasibility of 
such initiatives in clinical practice might be limited in the 
short term, however, given the current lack of evidence 
concerning solutions for further expediting care and 
logistics services at reasonable costs. For example, the 
goal of reducing time spent on the scene by ambulance 
personnel to less than 10 min or reducing DTN time to 
less than 20 min would probably be unrealistic, given the 
need to handle and observe the patient, to complete diag-
nostic tests and to interpret findings. Although further 
improvements in the proportion of patients calling 911 
directly following symptom onset could potentially result 
in further increases in IVT rates, they would also necessi-
tate large- scale and repetitive publicity campaigns compa-
rable to those launched to raise public awareness on 
stroke symptoms and how to act.
The organisational model for acute stroke care delivery 
is currently receiving a great deal of attention in the 
Netherlands, as well as beyond.40 41 The emergence of 
endovascular treatment (EVT) for patients facing large- 
vessel occlusions has opened up a whole new dimension 
in terms of acute stroke pathway set- up and patient logis-
tics. Following IVT, eligible patients must now undergo 
additional diagnostic evaluation (eg, CT angiography 
and perfusion CT), followed by such EVT treatment 
modalities as groin punctures and initial attempt at clot 
retrieval with the device up to the angioseal following 
successful recanalisation. In addition, within the current 
‘drip- and- ship’ treatment paradigm, eligible patients 
may initially be admitted to community hospitals before 
being transferred to comprehensive stroke centres with 
EVT capacity, thereby further increasing the number of 
logistical steps. Given the time- sensitive nature of acute 
stroke interventions, this extension of the pathway neces-
sitates the re- organisation of acute stroke care within 
regions and settings. In this respect, simulation model-
ling could facilitate insight into the complex interplay of 
separate elements of the pathway. Currently positioned as 
a follow- up treatment by current guidelines, availability of 
EVT does not change the need for optimising utilisation 
of IVT, nor does it impact the acute stroke pathway set- up 
for IVT. Moreover, the subgroup of patients eligible for 
EVT is relatively small, around 7% of all stroke patients.42
Our study is subject to several limitations. First, our 
simulation models did not consider the response of GPs 
when contacted as first responders. Although this has 
been signalled as an issue for delays in hospital arrival for 
patients,43 no studies on best practices were identified in the 
literature. Second, because the costs and cost- effectiveness 
associated with pathway improvements in our setting were 
not estimated in our model, it was not possible to control 
for them. Third, the results of our findings might not be 
generalisable to other settings, due to the unique position of 
the UMCG, which serves as a stroke centre in a centralised 
organisational model deployed within its region. As noted 
in a previous publication, however, the generic model-
ling approach adopted in this study could be extended 
to include a description of a decentralised organisational 
model, which receives IVT candidates within its own catch-
ment areas.23 Also, because patients were enrolled in the 
observational study back in 2010 these results will not fully 
reflect current practice. However, review of internal data-
bases show that IVT treatment percentages have remained 
largely stable over the last years, fluctuating around 25% 
with a DTN time of around 35 min. EMS response times have 
remained constant over the years.44 In addition, pathway 
set- up of acute stroke patients receiving IVT remained 
similar over the years. Finally, model assumptions excluded 
the possibility for capacity constraints influencing patient 
waiting times, as patients and/or transport queuing seldom 
occurs due to the high prioritisation that potential acute 
stroke patients receive throughout the pathway. However, 
we acknowledge that such constraints might occur in other 
stroke care systems. Future activities should be aimed at 
extending the simulation- based approach to include the 
drip- and- ship model currently employed in acute stroke 
treatment (eg, EVT).
COnCluSIOnS
The results of this study indicate that the cumulative 
effects of implementing best practices on the organisation 
of stroke care would clearly exceed current benchmarks 
for treatment rates. Remaining obstacles might be diffi-
cult to overcome given the limited availability of solution 
to further expedite care and logistical services at toler-
able costs. A broader overview facilitated by simulation is 
suggested as instrumental in supporting decision- makers 
and clinicians in their efforts to evaluate the set- up and 
performance of acute stroke pathways.
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